Paper25908451
The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer.
Boone BA and 10 others. Cancer Gene Ther, 2015. Cited by 154 papers, by iCite.
Cite this record
ConductScience Library. The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer. Papers, record 25908451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25908451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autophagy | Major topic |
| Carcinoma, Pancreatic Ductal | Major topic |
| Extracellular Traps | Major topic |
| Neutrophils | Major topic |
| Pancreatic Neoplasms | Major topic |
| Receptor for Advanced Glycation End Products | Major topic |
| Animals | |
| Female | |
| Humans | |
| Mice | |
| Mice, Knockout |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 CA113263 | NCI NIH HHS | United States | T32CA113263 | PubMed and NIH | NIH RePORTER |
| T32CA113263 | NCI NIH HHS | United States | T32CA113263 | PubMed and NIH | NIH RePORTER |
| P30CA047904 | NCI NIH HHS | United States | P30CA047904 | PubMed and NIH | NIH RePORTER |
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21698003 | Investigating the pathogenic role of PADI4 in oesophageal cancer. | Int J Biol Sci | 2011 | https://conductscience.org/library/papers/21698003 | PubMed |
| 2 | 18616529 | Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. | Cancer Sci | 2008 | https://conductscience.org/library/papers/18616529 | PubMed |
| 3 | 23508552 | A proposed role for neutrophil extracellular traps in cancer immunoediting. | Front Immunol | 2013 | https://conductscience.org/library/papers/23508552 | PubMed |
| 4 | 24740698 | Neutrophil extracellular traps promote differentiation and function of fibroblasts. | J Pathol | 2014 | https://conductscience.org/library/papers/24740698 | PubMed |
| 5 | 20706768 | Protein arginine deiminase 4: a target for an epigenetic cancer therapy. | Cell Mol Life Sci | 2011 | https://conductscience.org/library/papers/20706768 | PubMed |
| 6 | 23316068 | HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4. | Am J Physiol Lung Cell Mol Physiol | 2013 | https://conductscience.org/library/papers/23316068 | PubMed |
| 7 | 23722544 | Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis. | Cancer Res | 2013 | https://conductscience.org/library/papers/23722544 | PubMed |
| 8 | 24553385 | Detection of circulating tumor DNA in early- and late-stage human malignancies. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/24553385 | PubMed |
| 9 | 21126167 | The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury. | Antioxid Redox Signal | 2011 | https://conductscience.org/library/papers/21126167 | PubMed |
| 10 | 22052106 | RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. | J Gastrointest Surg | 2012 | https://conductscience.org/library/papers/22052106 | PubMed |
| 11 | 22044575 | Neutrophil extracellular traps promote deep vein thrombosis in mice. | J Thromb Haemost | 2012 | https://conductscience.org/library/papers/22044575 | PubMed |
| 12 | 20081861 | Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. | Nat Med | 2010 | https://conductscience.org/library/papers/20081861 | PubMed |
| 13 | 24465790 | Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes. | PLoS One | 2014 | https://conductscience.org/library/papers/24465790 | PubMed |
| 14 | 23227088 | Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase. | Clin Dev Immunol | 2012 | https://conductscience.org/library/papers/23227088 | PubMed |
| 15 | 23110523 | Identification of PADI2 as a potential breast cancer biomarker and therapeutic target. | BMC Cancer | 2012 | https://conductscience.org/library/papers/23110523 | PubMed |
| 16 | 19834494 | The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. | Cell Death Differ | 2010 | https://conductscience.org/library/papers/19834494 | PubMed |
| 17 | 22703527 | Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma. | Cancer Sci | 2012 | https://conductscience.org/library/papers/22703527 | PubMed |
| 18 | 23308284 | The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest. | PLoS One | 2013 | https://conductscience.org/library/papers/23308284 | PubMed |
| 19 | 22195044 | Neutrophil extracellular trap formation is associated with IL-1β and autophagy-related signaling in gout. | PLoS One | 2011 | https://conductscience.org/library/papers/22195044 | PubMed |
| 20 | 24449238 | Liquid biopsies: genotyping circulating tumor DNA. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/24449238 | PubMed |
Cited by119
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 154 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42732150 | Baseline Extracellular HMGB-1 Levels Associated with Induction Chemotherapy Response in Adult Acute Myeloid Leukemia. | F1000Res | 2026 | https://conductscience.org/library/papers/42732150 | PubMed |
| 42675156 | Neutrophil extracellular traps in tumor progression: from mechanistic insights and regulatory factors to clinical detection and diagnosis. | J Mol Med (Berl) | 2026 | https://conductscience.org/library/papers/42675156 | PubMed |
| 42596723 | Neutrophil-based immunotherapy: A metabolic lens on mechanisms and therapeutic implications. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42596723 | PubMed |
| 42485000 | Caught in the NET: A Review on the Emerging Role of Neutrophil Extracellular Traps in PDAC Development. | Technol Cancer Res Treat | 2026 | https://conductscience.org/library/papers/42485000 | PubMed |
| 42212337 | Neutrophil Extracellular Traps in Pancreatic Ductal Adenocarcinoma: A Vicious Cycle in the Tumor Microenvironment and Targeted Interventions. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42212337 | PubMed |
| 42099651 | Neutrophil count and platelet-lymphocyte ratio as simple predictors of ustekinumab response in patients with Crohn's disease: a retrospective multicenter study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42099651 | PubMed |
| 42023239 | Tumor-associated neutrophils in pancreatic ductal adenocarcinoma: mechanisms and therapeutic targeting. | Front Immunol | 2026 | https://conductscience.org/library/papers/42023239 | PubMed |
| 41981626 | Immunogenic cell death as a cornerstone for combination therapies with immune checkpoint blockade. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41981626 | PubMed |
| 41827874 | Neutrophil Extracellular Traps in Exocrine Pancreatic Disease: A Comprehensive Review of Pathogenesis, Severity Stratification, and Therapeutic Targeting. | Cells | 2026 | https://conductscience.org/library/papers/41827874 | PubMed |
| 41736666 | PAF Triggered Pyroptotic NETosis Aggravates Myocardial Ischemia/Reperfusion Injury. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41736666 | PubMed |
| 41648668 | Scavenger receptors: key players in the immunological puzzle of lupus. | Front Lupus | 2025 | https://conductscience.org/library/papers/41648668 | PubMed |
| 41617393 | Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41617393 | PubMed |
| 41565749 | Application of group A streptococcal collagen-like protein 1-expressing Lactococcus as a novel immunotherapeutic against pancreatic ductal adenocarcinoma. | Sci Rep | 2026 | https://conductscience.org/library/papers/41565749 | PubMed |
| 41496500 | Multi-omics analysis identifies PUS7 as an immune modulator driving NETs-mediated macrophage polarization in pancreatic cancer. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/41496500 | PubMed |
| 41411661 | Neutrophil extracellular trap inhibition revitalizes PDAC immunotherapy responsiveness via reduced fibrosis and TCF1+CD8+ progenitor T-cell expansion. | Oncoimmunology | 2025 | https://conductscience.org/library/papers/41411661 | PubMed |
| 41019086 | NETs - as predictors and targets of supportive therapy for cancer treatment. | Front Immunol | 2025 | https://conductscience.org/library/papers/41019086 | PubMed |
| 40805288 | Neutrophil Dynamics in Response to Cancer Therapies. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805288 | PubMed |
| 40797324 | Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibition. | J Inflamm (Lond) | 2025 | https://conductscience.org/library/papers/40797324 | PubMed |
| 40742388 | Neutrophil Extracellular Traps Modulate Recruitment and Immunosuppression of Macrophages in Pancreatic Adenocarcinoma. | Cancer Immunol Res | 2025 | https://conductscience.org/library/papers/40742388 | PubMed |
| 40282474 | Role of Neutrophils in Anti-Tumor Activity: Characteristics and Mechanisms of Action. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40282474 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AGER | 177 | PubTator's text mining | https://conductscience.org/library/genes/177 | NCBI Gene |
| ELANE | 1991 | PubTator's text mining | https://conductscience.org/library/genes/1991 | NCBI Gene |
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| PADI4 | 23569 | PubTator's text mining | https://conductscience.org/library/genes/23569 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25908451
GET https://conductscience.org/api/papers/v1/25908451/references?page=2